NFκB

You have access
Vanillin Analogues o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFĸB Activation and Suppress Growth of A375 Human Melanoma
ANNAMÁRIA MARTON, ERZSÉBET KÚSZ, CSONGOR KOLOZSI, VILMOS TUBAK, GIUSEPPE ZAGOTTO, KRISZTINA BUZÁS, LUIGI QUINTIERI and CSABA VIZLER

Anticancer Research November 2016, 36 (11) 5743-5750;
You have access
The NFκB Signaling Pathway in Papillomavirus-induced Lesions: Friend or Foe?
RUI M. GIL DA COSTA, MARGARIDA M.S.M. BASTOS, RUI MEDEIROS and PAULA A. OLIVEIRA

Anticancer Research May 2016, 36 (5) 2073-2083;
You have access
Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-regulation of STAT3–NFκB Signaling
SEYUNG S. CHUNG and JAYDUTT V. VADGAMA

Anticancer Research January 2015, 35 (1) 39-46;
You have access
Combination of Lipitor and Celebrex Inhibits Prostate Cancer VCaP Cells In Vitro and In Vivo
HUARONG HUANG, XIAO-XING CUI, SHAOHUA CHEN, SUSAN GOODIN, YUE LIU, YAN HE, DONGLI LI, HONG WANG, JEREMIAH VAN DOREN, ROBERT S. DIPAOLA, ALLAN H. CONNEY and XI ZHENG

Anticancer Research July 2014, 34 (7) 3357-3363;
You have access
Oxazine Derivatives of γ- and δ-Tocotrienol Display Enhanced Anticancer Activity In Vivo
SURYATHEJA ANANTHULA, PARASH PARAJULI, FATHY A. BEHERY, ALAADIN Y. ALAYOUBI, KHALID A. EL SAYED, SAMI NAZZAL and PAUL W. SYLVESTER

Anticancer Research June 2014, 34 (6) 2715-2726;
You have access
Desensitization of NFκB for Overcoming Chemoresistance of Pancreatic Cancer Cells to TNF-α or Paclitaxel
SHUICHI FUJIOKA, KYONSU SON, SHINJI ONDA, CHRISTIAN SCHMIDT, GUIDO M. SCRABAS, TOMOYOSHI OKAMOTO, TETSUJI FUJITA, PAUL J. CHIAO and KATSUHIKO YANAGA

Anticancer Research November 2012, 32 (11) 4813-4821;

Main menu

User menu

Search

NFκB